Premium
[P1–099]: SCREENING FDA‐APPROVED COMPOUNDS IN A TREM2 CELL MODEL OF ALZHEIMER's DISEASE
Author(s) -
Rutter Hannah,
Lim Yau Mun,
Corcoran Jonathan,
Hodges Angela
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.166
Subject(s) - trem2 , microglia , neuroprotection , receptor , phagocytosis , pharmacology , biology , immunology , cancer research , inflammation , biochemistry
P1-099 SCREENING FDA-APPROVED COMPOUNDS IN ATREM2 CELL MODEL OFALZHEIMER’S DISEASE Hannah Rutter, Yau Mun Lim, Jonathan Corcoran, Angela Hodges, King’s College London, Institute of Psychiatry, Psychology & Neuroscience, London, United Kingdom; King’s College London, Wolfson Centre of Age-Related Disease, London, United Kingdom; Maurice Wohl Clinical Neuroscience Institute James Black Centre Institute of Psychiatry, Psychology & Neuroscience (IoPPN) King’s College, London, United Kingdom. Contact e-mail: hannah.rutter@kcl.ac.uk